149 related articles for article (PubMed ID: 21870713)
1. [The alteration of proteins glycosylation in liver diseases].
Chrostek L; Cylwik B
Pol Merkur Lekarski; 2011 Jul; 31(181):60-4. PubMed ID: 21870713
[TBL] [Abstract][Full Text] [Related]
2. Alteration of protein glycosylation in liver diseases.
Blomme B; Van Steenkiste C; Callewaert N; Van Vlierberghe H
J Hepatol; 2009 Mar; 50(3):592-603. PubMed ID: 19157620
[TBL] [Abstract][Full Text] [Related]
3. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
[TBL] [Abstract][Full Text] [Related]
4. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.
Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E
Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676
[TBL] [Abstract][Full Text] [Related]
5. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases.
Anderson N; Pollacchi A; Hayes P; Therapondos G; Newsome P; Boyter A; Smith K
Biomed Chromatogr; 2002 Sep; 16(6):365-72. PubMed ID: 12228891
[TBL] [Abstract][Full Text] [Related]
6. [Effect of various types of liver diseases on the behavior of cefoperazone].
Malè PJ; Dayer P; Châtelain G; Rudhardt M; Fabre J
Schweiz Med Wochenschr; 1983 Dec; 113(49):1860-3. PubMed ID: 6676938
[TBL] [Abstract][Full Text] [Related]
7. [The behavior of albumin in acute and chronic liver damage. III. Intrahepatic and serum albumin concentrations in human liver diseases].
Rogos R
Z Gesamte Inn Med; 1978 Aug; 33(15):506-12. PubMed ID: 695790
[TBL] [Abstract][Full Text] [Related]
8. The liver and circulating thyroid hormones.
Klachko DM; Johnson ER
J Clin Gastroenterol; 1983 Oct; 5(5):465-71. PubMed ID: 6313798
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid gland and thyroid status in patients with chronic liver diseases].
Podymova SD; Ulanova IN; Bolśhakova TD; Khomiakova VN
Klin Med (Mosk); 1997; 75(3):32-5. PubMed ID: 9229611
[No Abstract] [Full Text] [Related]
10. Proteomics in the study of liver pathology.
Parent R; Beretta L
J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398
[No Abstract] [Full Text] [Related]
11. Cell surface protein glycosylation in cancer.
Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
[TBL] [Abstract][Full Text] [Related]
12. [Hematologic masks in liver diseases].
Tentsova IA
Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):43-7. PubMed ID: 6792623
[No Abstract] [Full Text] [Related]
13. Serum gamma-glutamyl transpeptidase: its clinical significance.
Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.
Cheung KJ; Libbrecht L; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1066-73. PubMed ID: 20186066
[TBL] [Abstract][Full Text] [Related]
15. [Study on expression of P16 protein in the liver tissue of viral hepatitis].
Xin S; Wang L; Wang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):122-4. PubMed ID: 12515187
[TBL] [Abstract][Full Text] [Related]
16. The influence of host factors on drug response. VI. Hepatocellular diseases.
Vesell ES
Ration Drug Ther; 1981 Aug; 15(8):1-8. PubMed ID: 7347855
[No Abstract] [Full Text] [Related]
17. Hepatic diseases in the elderly.
Van Dam J; Zeldis JB
Gastroenterol Clin North Am; 1990 Jun; 19(2):459-72. PubMed ID: 2163984
[TBL] [Abstract][Full Text] [Related]
18. Fucosylated glycoproteins as markers of liver disease.
Mehta A; Block TM
Dis Markers; 2008; 25(4-5):259-65. PubMed ID: 19126969
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of precursors into sterols and proteins in liver biopsies from patients with liver disorders.
Evensen SA; Ritland S; Elgjo K; Solberg HE; Skrede S
Scand J Gastroenterol; 1984 Jan; 19(1):6-13. PubMed ID: 6143395
[TBL] [Abstract][Full Text] [Related]
20. Hepatic and blood lead levels in patients with chronic liver disease.
Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
